American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

FDA Issues Recommendations for Parents, Industry on Infant Vitamin D Supplements

Products Pose Potential Overdose Risk

By News Staff

The FDA is warning consumers about the risk of overdosing infants with liquid vitamin D supplements.
Photo of Ellie Mitchell getting ready to take her vitamin D drops
The FDA is warning consumers about the potential for overdosing infants with vitamin D liquid drops.
In 2008, the American Academy of Pediatrics doubled the recommended daily intake of vitamin D for infants and children from 200 international units, or IU, a day to 400 IU.

But Linda Katz, M.D., M.P.H., interim chief medical officer in the agency's Center for Food Safety and Applied Nutrition, said in a June 15 teleconference that some liquid vitamin D products come with droppers that can hold significantly more than the recommended amount of liquid vitamin D.

In a June 15 letter to manufacturers, the FDA recommended that 400 units be clearly and accurately marked on droppers packaged with vitamin D supplements. It also recommended that products intended specifically for infants have droppers that hold no more than 400 units.

Vitamin D promotes calcium absorption and plays a key role in the development of strong bones. However, Katz said excessive vitamin D can cause nausea, vomiting, loss of appetite, excessive thirst, frequent urination, constipation, abdominal pain, muscle weakness, muscle and joint aches, confusion, fatigue, and kidney damage.

The agency said other potential serious consequences of overdose may include cardiac arrhythmias, osteomalacia and hypercalcemia, which can lead to soft-tissue deposition of calcium, resulting in other associated problems, such as hypertension.

The agency issued a number of recommendations aimed at parents and other caregivers.
  • Ensure that your infant does not receive more than 400 IU of vitamin D a day.
  • Keep the vitamin D supplement product with its original package so that you and other caregivers can follow the dosing instructions. Follow these instructions carefully and give the correct dose.
  • Use only the dropper that comes with the product because it is manufactured specifically for that product.
  • Ensure the dropper is marked so that the units of measure are clear and easy to understand. Also make sure that the units of measure correspond to those mentioned in the instructions.
  • If you cannot clearly determine the dose of vitamin D delivered by the dropper, talk to a health care professional before giving the supplement to your infant.
  • If your infant is being fully or partially fed with infant formula, check with your physician before giving the child vitamin D supplements.
Physicians and consumers are encouraged to report adverse events or side effects related to the use of vitamin D liquid products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

Although vitamin D overdose is a serious issue, a study published in the April issue of Pediatrics found that the vast majority of U.S. infants don't receive enough vitamin D.

Researchers found that no more than 13 percent of infants who were strictly breastfed met either a 2003 recommendation for 200 IU of vitamin D or the 2008 recommendation of 400 IU. As many as 35 percent of infants who received breast milk and formula met the 2003 recommendation, but only 9 percent to 14 percent met the 2008 recommendation.

Of infants who received only formula, 81 percent to 98 percent met the 2003 recommendation, but less than 40 percent met the 2008 recommendation.

Researchers concluded that physicians should encourage parents of infants who either are exclusively breastfed or who consume less than one liter of formula a day to give their infants an oral vitamin D supplement.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

Remain Vigiliant for Novel Coronavirus, Says CDC

DTaP Remains in Short Supply This Summer

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control